Filter by
Selections
July 6, 2016
Arrowhead Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
Read MoreJune 9, 2016
Arrowhead Pharmaceuticals Initiates Phase 1/2 Single and Multiple Dose Study of Hepatitis B Candidate ARC-521
Read MoreJune 3, 2016